FDA approved combination clearances for Elanco's Experior use on June 27, 2025.
2 reports, 1 independent
Updated Jun 28
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA approved combination clearances for Elanco's Experior use on June 27, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.First confirmed screwworm case in Texas livestock; industry thanks FDA for preparation.1 source
- FDA grants combination clearance for Elanco's Experior.
Keep exploring
The entities involved
Related events
- Modular is seeking FDA clearance for its Pivot product.
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.
- FDA approval enables commercial opportunity involving CBRE Group.
- Unregulated products are bypassing official government approval processes.
- Future sales of a product are contingent upon obtaining the necessary FDA registration and labeling, while the state simultaneously announces actions to remove regulatory barriers.
Coverage
Newest first; wire copies grouped- hpj.com
- Unknown outlet